Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968731 · ClinicalTrials.gov registry record · NA
Meibomian Gland Dysfunction Management With ZEST Protocol
A NA study, sponsored by University of the Incarnate Word.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03968731 is a NA study that has completed, run by University of the Incarnate Word. The registered enrollment target is 30 participants.
The verdict
NCT03968731, a NA study, has completed, sponsored by University of the Incarnate Word.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate if cleaning the eyelid margin with the ZEST protocol (Zocular Eyelid System Treatment) in patients intolerant to contact lens wear consequent to Meibomian gland dysfunction (MGD) will improve the MGD and contact lens wear comfort.
Interventions
- OTHER Zocular Eyelid System Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-06-10 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03968731
The ClinicalTrials.gov registry entry for NCT03968731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of the Incarnate Word, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zocular Eyelid System Treatment is the first listed.
NCT03968731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03968731 about?
NCT03968731 is a clinical study titled "Meibomian Gland Dysfunction Management With ZEST Protocol". The purpose of this study is to investigate if cleaning the eyelid margin with the ZEST protocol (Zocular Eyelid System Treatment) in patients intolerant to contact lens wear consequent to Meibomian gland dysfunction (MGD) will improve the MGD and contact lens wear comfort.
What is the current status of trial NCT03968731?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-10. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03968731?
The interventions under investigation include: Zocular Eyelid System Treatment (OTHER).
Who is sponsoring clinical trial NCT03968731?
This trial is sponsored by University of the Incarnate Word, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.